1. Xi Zhang#, Fengwei Jiao#, Guangrun Li, Xiaojia Yu, Yuqing Pei, Ying Zhang, Zihui Wang* and Pengfei Li*.Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants.Frontiers in Pharmacology.2023.14.1-6.SCI |
2. Du Ping, Zhao Zhixia, Yu Weiyue, Zhao Rui, Liu Hongchuan, Li Pengfei*, Liu Lihong*.Pharmacokinetics, bioequivalence, and safety studies of gefitinib tablet formulations: A randomized, open-label, two-period, two-sequence crossover study in Chinese healthy volunteers.OURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY.2023.84.104563.SCI |
3. 张文杰, 李鹏飞*.液相色谱-串联质谱法测定人血清中25-羟基维生素D的浓度及临床应用.中国临床药理学杂志.2023.39, (12).1787-1791.核心期刊 |
4. 张文杰,杨缓缓,李鹏飞*.基于液相色谱串联质谱的他克莫司检测试剂盒的研制和评价.解放军药学学报.2023.36, (3).203-207.核心期刊 |
5. Pengfei Li, Haitang Wu, Zhixia Zhao, Ping Du, Haitong Xu, Hongchuan Liu, Yu Zhou, Weiyue Yu, Hao Li* and Lihong Liu*.Simultaneous Quantitation of Clevidipine and Its Active Metabolite H152/81 in Human Whole Blood by LC-MS/MS: Application to Bioequivalence Study.Frontiers in Chemistry.2022.10.1-9.SCI |
6. Xi Zhang#, Xinbei Jia#, Weihang Tong, Hui Chen, Ning Lei, Guangrun Li, Jun Tai* and Pengfei Li *.Quantification of clofarabine in urine and plasma by LC-MS/MS: suitable for PK study and TDM in pediatric patients with relapsed or refractory ALL.RSC ADVANCES.2022.12.33091-33098.SCI |
7. Xi Zhang, Zhuoling An, Yali Lv, Guangrun Li, Lihong Liu*, Pengfei Li*.Simultaneous determination of RDX and HMX in rat plasma by LC-MS/MS and its applications.Frontiers in chemistry.2022.10.1-8.SCI |
8. Pengfei Li, Xi Zhang, Shumin Wang, Jing Wang, Ziqi Liu, Chen Wang, Weihang Tong* and Lihong Liu*.Development of a rapid LC-MS/MS assay to determine letrozole in human plasma and its application in a pharmacokinetic study after oral administration.ACTA CHROMATOGRAPHICA.2022.34 (2).179-184.SCI |
9. 张茜, 童卫杭, 吕亚丽, 陈慧, 雷宁, 李广润, 李鹏飞*.液相色谱-串联质谱法测定人血浆中氯法拉滨的浓度.中国临床药理学杂志.2022.38, (7).711-715.核心期刊 |
10. Pengfei Li#, Yuting Cong#, Wen Zhang#, Lefeng Wang, Lulu Ren, Xin Li, Song Yang, Zhiyong Zhang, Guoqing Li* and Lihong Liu*.Simultaneous quantification of apolipoproteins A-I, E, and J in human plasma by LC-MS/MS for clinical application to diabetes mellitus complicated with cardiovascular disease.RSC ADVANCES.2022.12 (26).16763-16771.SCI |
11. Pengfei Li#, Jun Peng#, Yuexin Li , Lili Gong, Yali Lv, He Liu, Tianhong Zhang, Song Yang, Hongchuan Liu, Jinglai Li, Lihong Liu*.Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Finding Out the Causes Leading to the Ultra-low Oral Bioavailability and Identifying the Metabolic Pathway.Frontiers in Pharmacology.2021.12.1-12.SCI |
12. An Zhuoling#, Wang Xiangyi#, Li Pengfei#, He Jiuming, Liu Lihong*. Exploring the metabolic characteristics and pharmacokinetic variation of paroxetine in healthy volunteers using a pharmacometabonomic approach.Journal of Pharmaceutical and Biomedical Analysis.2021.204.1-12.SCI |
13. 李鹏飞, 范家明, 张茜, 杜萍, 刘河, 刘洪川, 刘丽宏*.HPLC-MS/MS法测定血浆中百草枯浓度的不确定度评定.中国临床药理学杂志.2020.36, (23).3938-3942.核心期刊 |
14. Zirui Wan#, Lifang Guo#, Pengfei Li#, Zhixia Zhao, Benshan Xu, Lulu Ren, Yan Yan, He Liu, Yiwen Zhang, Lihong Liu*.Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters.J Clin Pharm Ther.2020.45 (5).1159-1167.SCI |
15. 李鹏飞, 赵志霞, 张希涛, 于伟越, 杜萍, 刘洪川, 刘丽宏*.Ⅰ期临床研究中健康受试者筛选成败的原因分析.中国临床药理学杂志.2019.35, (13).1391-1394.核心期刊 |
16. 李鹏飞, 范家明, 刘河, 张茜, 安卓玲, 刘丽宏*.大鼠体内百草枯组织分布研究.首都医科大学学报.2019.40(5).726-730.核心期刊 |
17. 范家明#, 李鹏飞#, 刘丽宏, 赵瑞, 赵志霞, 杜萍, 刘河*.大鼠体内的百草枯毒代动力学研究.中国临床药理学杂志.2019.35, (3).280-282.核心期刊 |
18. Jiaming Fan#, Pengfei Li#, He Liu, Rui Zhao, Zhixia Zhao, Ping Du, Lihong Liu*.Optimized Liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of paraquat in plasma:application to a toxicokinetics study. Analytical methods.2019.11(21).2756-2762.SCI |